Philly daily roundup: AI to use old drugs for new cures; Top 10 for life science projects; DiverseForce graduates board hopefuls

AI finds new uses for old drugs at Every Cure

Every Cure is focused on finding ways to use existing medicines to treat diseases for which they weren’t initially intended or developed — aka “drug repurposing.”

Cofounded by a Penn prof battling his own rare disease, the nonprofit is building a biomedical knowledge graph using large language models to review medical literature and identify relationships between biomedical concepts. The graph will reflect connections between drugs and diseases to help as many patients as possible.

➡️ Read more about Every Cure’s mission here

30+ vendors strut their stuff for Philly biotech

The University City Science Center was packed to the brim last Wednesday with more than 30 major life sciences companies and organizations displaying new technologies and services at the second annual Life Science Vendor Showcase.

“With the biotech industry just blowing up, especially here in the Philadelphia area, it’s really important for us to be able to introduce ourselves to the new companies, the new people moving in,” Kristen Hightower, senior technical sales specialist for Thermo Fisher Scientific, told Technical.ly.

➡️ Read more about the vendors that attended the showcase here

News Incubator: What else to know today

• The Department of Justice filed its antitrust lawsuit against Apple — and instead of filing in DC or California, the suit was filed in New Jersey. We chatted with a law prof and found the likely reason why. [Technical.ly]

• Two Philly life sciences projects are among the 10 largest in the nation, according to a report from real estate agency Commercial Search: 3201 Cuthbert St., a Drexel-connected tower; and 3151 Market St., part of Schuylkill Yards, which is also a Drexel venture. [CommercialSearch/Drexel/Brandywine]

• DiverseForce graduated the 11th cohort of its On Boards program, which works to connect professionals of color with nonprofit boards. [YouTube]

• Self-administered injectable medications lead to more independence and more adherence to treatment plans. That’s the opinion of more than 90% of healthcare providers and patients in a survey from West Pharmaceuticals. [LinkedIn/Technical.ly]

🗓️ On the Calendar